| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/10/2002 | WO2002002623A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | WO2002002152A1 Photodynamic treatment and uv-b irradiation of a thrombocyte suspension |
| 01/10/2002 | WO2002002140A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
| 01/10/2002 | WO2002002138A1 Treating endotoxemia and related disorders with probiotics |
| 01/10/2002 | WO2002002051A2 Use of a polysaccharide excreted by the vibrio diabolicus species in bone repair |
| 01/10/2002 | WO2001074164A9 Methods of modulating hair growth |
| 01/10/2002 | WO2001070175A3 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 01/10/2002 | WO2001059071A3 Methods of preparing and using a viral vector library |
| 01/10/2002 | WO2001051066A3 Reduction in bacterial colonization by administering bacteriophage compositions |
| 01/10/2002 | WO2001051027A3 Polymer blends as biodegradable matrices for preparing biocomposites |
| 01/10/2002 | WO2001050881A3 Process and composition for controlling fecal hair excretion and trichobezoar formation |
| 01/10/2002 | WO2001043787B1 A process for preparing an autologous platelet gel and membrane thereof |
| 01/10/2002 | WO2001042444A3 Methods for expression of genes in primates |
| 01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 01/10/2002 | WO2001028573A3 Monocyte conditioned medium for cancer treatment |
| 01/10/2002 | WO2001000829A3 Human endogenous retrovirus in breast cancer |
| 01/10/2002 | WO2000075347A3 Tet repressor-based transcriptional regulatory proteins |
| 01/10/2002 | WO2000066162A9 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/10/2002 | US20020004519 Diarrhea therapy |
| 01/10/2002 | US20020004240 Method and system for introducing a gene into a human stem cell |
| 01/10/2002 | US20020004192 Decolorized animal blood products and method of making same |
| 01/10/2002 | US20020004073 Condensing in presence of catalytic thiol unoxidized sulfhydryl side chain of n-terminal cysteine of one oligopeptide with c-terminal thioester of other to produce intermediate bond, then rearranging to produce amide bond |
| 01/10/2002 | US20020004048 Hepatitis C virus asialoglycoproteins |
| 01/10/2002 | US20020004044 Methods for inducing the differentiation of monocytes into functional dendritic cells |
| 01/10/2002 | US20020004040 Complementary adenoviral vector systems and cell lines |
| 01/10/2002 | DE10128980A1 Genetically modified T cells, useful e.g. for inhibiting allogenic transplant rejection, produced by incubating recipient and donor T cells then transducing with immunomodulatory gene |
| 01/10/2002 | CA2414596A1 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/10/2002 | CA2414347A1 Vaccine comprising active agent immunogenic acyl glyceryl phosphatidylinositol manno-oligosaccharide |
| 01/10/2002 | CA2414328A1 Chimeric promoters for controlling expression in smooth muscle cells |
| 01/10/2002 | CA2413237A1 Alteration of cell membrane for new functions |
| 01/09/2002 | EP1170368A2 Immunization by inoculation of dna transcription unit |
| 01/09/2002 | EP1170363A1 Virus envelope vector for gene transfer |
| 01/09/2002 | EP1169480A1 Tissue-specific and pathogen-specific toxic agents and ribozymes |
| 01/09/2002 | EP1169469A1 Human colon cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1169465A1 Two-step immunization procedure against chlamydia infection |
| 01/09/2002 | EP1169446A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 01/09/2002 | EP1169444A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 01/09/2002 | EP1169441A2 Treatment of cardiac power failure using s100 proteins |
| 01/09/2002 | EP1169348A1 Purposeful movement of human migratory cells away from an agent source |
| 01/09/2002 | EP1169347A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/09/2002 | EP1169346A1 48 human secreted proteins |
| 01/09/2002 | EP1169345A2 Genes associated with diseases of the kidney |
| 01/09/2002 | EP1169342A2 Tuberculosis antigens and methods of use therefor |
| 01/09/2002 | EP1169340A1 Lantibiotic |
| 01/09/2002 | EP1169069A1 Three-dimensional stromal tissue |
| 01/09/2002 | EP1169063A2 Treatment of intracellular infection |
| 01/09/2002 | EP1169056A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases |
| 01/09/2002 | EP1169054A2 Products and methods for treating ptp lar related diseases |
| 01/09/2002 | EP1169045A2 Immunomodulating polymers |
| 01/09/2002 | EP1168924A1 In vitro induction of antigen-specific t-cells using dendritic cell-tumor cell or dendritic cell-viral cell derived immunogens |
| 01/09/2002 | EP1168917A2 Human lung cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP0984699A4 Method of inhibiting immune system destruction of transplanted viable cells |
| 01/09/2002 | EP0702561B1 Treatment of neuromuscular disorders and conditions with botulinum serotyp e |
| 01/09/2002 | EP0683671B1 Immune system modulation using psoralens activated with visible light |
| 01/09/2002 | CN1330715A Selectively replicating viral vectors |
| 01/09/2002 | CN1330714A Virulence genes and proteins and their use |
| 01/09/2002 | CN1330557A In situ injection of antigen-presenting cells with generatically enhanced cytokine expression cell factor |
| 01/09/2002 | CN1330549A Method for preventing and reversing atherosclerosis in mammals |
| 01/09/2002 | CN1330517A Food-induced antisecretory proteins in egg yolk |
| 01/09/2002 | CN1329925A Biologically cmposite artificial bone and its preparing process |
| 01/09/2002 | CN1329916A Chinese medicine for treating rheumatism and rheumatoid diseases |
| 01/09/2002 | CN1329913A Live-nourishing 'yanggan' pill |
| 01/09/2002 | CN1329901A Exterior-applied black plaster for treating bone diseases and its preparing process |
| 01/09/2002 | CN1329896A Medical wine for treating rheumatism, rheumatoid diseases and hyperosteogeny |
| 01/09/2002 | CN1329895A Exterior-applied ointment for treating hyperosteogeny |
| 01/09/2002 | CN1329893A Chinese medicine for decreasing fat and lossing weight and preparation method thereof |
| 01/09/2002 | CN1329892A Synergestic coating liquid for double skin needling |
| 01/09/2002 | CN1329885A Preparing process and application of clam lipoid |
| 01/09/2002 | CN1077437C Chinese patent medicine for treating prostatic disorders |
| 01/09/2002 | CN1077436C Anrutong capsule for treatment of mammary-gland disease |
| 01/09/2002 | CN1077409C Preparation process of insects protein powder |
| 01/08/2002 | US6337214 Detection of DNA, RNA and proteins using a test column with two snares |
| 01/08/2002 | US6337209 Molecular constructs containing a carcinoembryonic antigen regulatory sequence |
| 01/08/2002 | US6337184 Detecting expression of a gene operatively linked to bcl-2, an apoptosis inhibition protein, within myogenic cells, as an indication the the myogenic cell is a muscle stem cell |
| 01/08/2002 | US6337093 Immunomodulatory and antimicrobial materials, their preparation and use |
| 01/08/2002 | US6337088 Selecting a bacteriophage having dimensions similar to virus; loading bacteriophage into jacket comprising hollow fiber, sealing top and bottom ends, placing jacket into bath solution, inoculating lawn of bacteria, calculating retention |
| 01/08/2002 | US6337075 Methods for treating diabetes |
| 01/08/2002 | CA2246222C Tumor rejection antigens presented by hla-b44 molecules, and uses thereof |
| 01/08/2002 | CA2163636C Process for the sterilization of biological compositions and the product produced thereby |
| 01/08/2002 | CA2148138C Biological factors and neural stem cells |
| 01/08/2002 | CA2135346C Natural mixture composed of higher primary aliphatic alcohols obtained from bee wax for the treatment of gastric and duodenal ulcers that also presents antiinflamatory activity |
| 01/03/2002 | WO2002000906A2 Replication deficient adenoviral tnf vector |
| 01/03/2002 | WO2002000883A2 Rescue of canine distemper virus from cdna |
| 01/03/2002 | WO2002000871A2 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current |
| 01/03/2002 | WO2002000868A1 Manipulation of negative stranded rna viruses by rearrangement of their genes and uses thereof |
| 01/03/2002 | WO2002000849A1 Cell fraction containing cells capable of differentiating into nervous system cells |
| 01/03/2002 | WO2002000778A1 The preparation method of a stable polymer aqueous phase-aqueous phase emulsion and its use |
| 01/03/2002 | WO2002000713A1 Prion-binding activity in serum and plasma determined as plasminogen and fibrinogen |
| 01/03/2002 | WO2002000266A2 A method of treating and preventing infectious diseases |
| 01/03/2002 | WO2002000242A2 Human papilloma virus treatment |
| 01/03/2002 | WO2002000238A1 Compositions promoting alcohol metabolism |
| 01/03/2002 | WO2002000234A1 A pharmaceutical preparation of chinese herbs for preventing and treating cardiovascular and cerebrovascular disease and the use thereof |
| 01/03/2002 | WO2002000233A2 Purging of cells using viruses |
| 01/03/2002 | WO2002000174A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/03/2002 | WO2002000172A2 Methods for using tetanus toxin for benificial purposes in animals (mammals) |
| 01/03/2002 | WO2001071005A3 Multifunctional polypeptides comprising a binding site to an epitope of the nkg2d receptor complex |
| 01/03/2002 | WO2001058472A3 Botulinum toxin pharmaceutical compositions |
| 01/03/2002 | WO2001053461A9 Multipotent neural stem cells from peripheral tissues and uses thereof |
| 01/03/2002 | WO2001053344A3 Chondromodulin-i related peptide |
| 01/03/2002 | WO2001046696A3 Methods and compositions for detecting hepatitis e virus |